Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
17-AAG in Systemic Mastocytosis
NCT00132015Phase 2Completed
- Sponsor
- National Institutes of Health
- Start
- May 2006
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tanespimycin in systemic mastocytosis (SM), sponsored by National Institutes of Health. Started May 2006; status: completed.
02
Drugs
tanespimycin
03
Conditions
systemic mastocytosis (SM)
Beyond the preview
Go deeper on NCT00132015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00132015.